Helen Ginn
About Helen Ginn
Helen Ginn is a Post Doctoral Researcher at Diamond Light Source, where she has worked since 2017. She holds a DPhil in Structural Biology from the University of Oxford and has contributed to significant research on coronavirus variants.
Work at Diamond Light Source
Helen Ginn has been employed at Diamond Light Source as a Post-doctoral Researcher since 2017. In this role, she focuses on advanced research in structural biology. Prior to her current position, she worked as a Software Scientist at Diamond Light Source from 2014 to 2017, where she contributed to various projects. Her work included developing methods for antibody mapping of coronavirus and antigenic mapping between variants. She also collaborated closely with Public Health England in a supervisory capacity to monitor coronavirus variants.
Education and Expertise
Helen Ginn studied at the University of Oxford, where she earned her DPhil in Structural Biology from 2013 to 2017. Prior to this, she completed her MBiochem in Molecular and Cellular Biochemistry at the same institution from 2008 to 2013. Her educational background provides her with a strong foundation in biochemistry and structural biology, which she applies in her research and development work.
Background
Helen Ginn has a diverse background in software development and scientific research. She briefly worked as a Software Developer at the University of Oxford in 2013 for two months. Her early experience as a Software Scientist at Diamond Light Source in 2012 for three months laid the groundwork for her later roles in the organization. This combination of software expertise and scientific knowledge has informed her research practices.
Publications and Research Contributions
Helen Ginn has made significant contributions to scientific literature, having published five papers in the journal Cell and one paper in the journal Science. Her research focuses on structural biology and has implications for understanding viral variants and antibody interactions, particularly in the context of coronavirus.